P

PreComb Therapeutics

13 employees

PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Combination therapies
Life Science
Personalized oncology
Life science
AI
3D tissue culture
Health Care
Oncology
Precision medicine
Medtech
Cancer therapy
Therapeutics
Drug profiling
Healthcare

Date founded

2018

Funding rounds raised

Total raised

$2.4M

from 4 investors over 4 rounds

P

PreComb Therapeutics raised $1.3M on October 4, 2022

Investors: LongeVC and Kinled Holding Ltd

P

PreComb Therapeutics raised $2.4M on April 27, 2021

Investors: Kinled Holding Ltd and High-Tech Gründerfonds

FAQ